台新藥眼部新藥 APP13007葡萄牙市場 授權 DÁVI 藥業

台新藥(6838)1日宣布,公司已與葡萄牙DÁVI藥業公司簽訂獨家授權協議,授予其APP13007(丙酸氯倍他索點眼懸液...Ads Links by Easy Branches
Play online games for free at games.easybranches.com

Guest Post Services www.easybranches.com/contribute